Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?

Pub Date : 2023-07-31 eCollection Date: 2023-07-01 DOI:10.2478/jccm-2023-0022
E Carlos Sanchez, Michael R Pinsky, Sharmili Sinha, Rajesh Chandra Mishra, Ahsina Jahan Lopa, Ranajit Chatterjee
{"title":"Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?","authors":"E Carlos Sanchez, Michael R Pinsky, Sharmili Sinha, Rajesh Chandra Mishra, Ahsina Jahan Lopa, Ranajit Chatterjee","doi":"10.2478/jccm-2023-0022","DOIUrl":null,"url":null,"abstract":"<p><p>Septic shock is a common condition associated with hypotension and organ dysfunction. It is associated with high mortality rates of up to 60% despite the best recommended resuscitation strategies in international guidelines. Patients with septic shock generally have a Mean Arterial Pressure below 65 mmHg and hypotension is the most important determinant of mortality among this group of patients. The extent and duration of hypotension are important. The two initial options that we have are 1) administration of intravenous (IV) fluids and 2) vasopressors, The current recommendation of the Surviving Sepsis Campaign guidelines to administer 30 ml/kg fluid cannot be applied to all patients. Complications of fluid over-resuscitation further delay organ recovery, prolong ICU and hospital length of stay, and increase mortality. The only reason for administering intravenous fluids in a patient with circulatory shock is to increase the mean systemic filling pressure in a patient who is volume-responsive, such that cardiac output also increases. The use of vasopressors seems to be a more appropriate strategy, the very early administration of vasopressors, preferably during the first hour after diagnosis of septic shock, may have a multimodal action and potential advantages, leading to lower morbidity and mortality in the management of septic patients. Vasopressor therapy should be initiated as soon as possible in patients with septic shock.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425929/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2478/jccm-2023-0022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Septic shock is a common condition associated with hypotension and organ dysfunction. It is associated with high mortality rates of up to 60% despite the best recommended resuscitation strategies in international guidelines. Patients with septic shock generally have a Mean Arterial Pressure below 65 mmHg and hypotension is the most important determinant of mortality among this group of patients. The extent and duration of hypotension are important. The two initial options that we have are 1) administration of intravenous (IV) fluids and 2) vasopressors, The current recommendation of the Surviving Sepsis Campaign guidelines to administer 30 ml/kg fluid cannot be applied to all patients. Complications of fluid over-resuscitation further delay organ recovery, prolong ICU and hospital length of stay, and increase mortality. The only reason for administering intravenous fluids in a patient with circulatory shock is to increase the mean systemic filling pressure in a patient who is volume-responsive, such that cardiac output also increases. The use of vasopressors seems to be a more appropriate strategy, the very early administration of vasopressors, preferably during the first hour after diagnosis of septic shock, may have a multimodal action and potential advantages, leading to lower morbidity and mortality in the management of septic patients. Vasopressor therapy should be initiated as soon as possible in patients with septic shock.

Abstract Image

分享
查看原文
脓毒性休克治疗中的液体和早期血管加压剂:我们是否已经有了正确的答案?
脓毒性休克是一种常见病,伴有低血压和器官功能障碍。尽管国际指南推荐了最佳的复苏策略,但其死亡率仍高达 60%。脓毒性休克患者的平均动脉压一般低于 65 毫米汞柱,低血压是决定这类患者死亡率的最重要因素。低血压的程度和持续时间非常重要。目前,"脓毒症生存运动 "指南建议每公斤输液 30 毫升,但这一建议并不适用于所有患者。过度输液会导致并发症,进一步延误器官恢复、延长重症监护室和住院时间并增加死亡率。对循环休克患者进行静脉输液的唯一原因是提高患者的平均全身充盈压,使其对容量有反应,从而增加心输出量。使用血管加压剂似乎是一种更合适的策略,尽早使用血管加压剂,最好是在确诊脓毒性休克后的第一个小时内使用,可能具有多模式作用和潜在优势,从而降低脓毒症患者的发病率和死亡率。脓毒性休克患者应尽快开始使用血管加压疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信